Table 3.

HLA donor-specific antibody MFI before and after treatment with bortezomib

Patient 1	DR13	DR15	DR51	DR52
Time
7 days before bortezomib first dose	20708	1618	2151	3881
146 days after bortezomib last dose	892	0	21	214
Patient 2	DQ2	DQ6	–	–
Time
7 days before bortezomib first dose	2658	5877	–	–
110 days after bortezomib last dose	1062	3658	–	–
7 days after last bortezomib + PP	312	1416	–	–
Patient 3	B51	Cw2	DQ7	–
Time
7 days before bortezomib first dose	1121	1963	5574	–
7 days after bortezomib last dose	293	939	5996	–

PP = plasmapheresis.